Showing results (61-70 of 247) with videos related to

Sort By:
Pageof 25
Gynecologic Oncology|January 29, 2010
FGFR2 mutations are rare across histologic subtypes of ovarian cancerSara A Byron, Michael G Gartside, Candice L Wellens, et al.
Cancer Research|November 13, 2003
The gene expression response of breast cancer to growth regulators: patterns and correlation with tumor expression profilesHeather E Cunliffe, Markus Ringnér, Sven Bilke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2013
Copy number aberrations of genes regulating normal thymus development in thymic epithelial tumorsIacopo Petrini, Yisong Wang, Paolo A Zucali, et al.
Molecular Cancer Therapeutics|January 26, 2017
PI3K Inhibitors Synergize with FGFR Inhibitors to Enhance Antitumor Responses in FGFR2mutant Endometrial CancersLeisl M Packer, Xinyan Geng, Vanessa F Bonazzi, et al.
Bone Research|April 15, 2020
Correction: Humanized bone facilitates prostate cancer metastasis and recapitulates therapeutic effects of Zoledronic acid in vivoMarietta Landgraf, Christoph A Lahr, Alvaro Sanchez-Herrero, et al.
Nucleic Acids Research|February 26, 2015
EWS-FLI1 employs an E2F switch to drive target gene expressionRaphaela Schwentner, Theodore Papamarkou, Maximilian O Kauer, et al.
Plos One|December 1, 2022
Kidney tumors associated with germline mutations of FH and SDHB show a CpG island methylator phenotype (CIMP)Christopher J Ricketts, J Keith Killian, Cathy D Vocke, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 15, 2011
Genome-wide methylation profiling in archival formalin-fixed paraffin-embedded tissue samplesJ Keith Killian, Robert L Walker, Sven Bilke, et al.
Bone Research|October 25, 2019
Humanized bone facilitates prostate cancer metastasis and recapitulates therapeutic effects of zoledronic acid in vivoMarietta Landgraf, Christoph A Lahr, Alvaro Sanchez-Herrero, et al.
Pageof 25